European Regulator Expands Ozempic Probe To Include Other Weight Loss Drugs Over Suicide Risks – Novo Nordisk (NYSE:NVO), Eli Lilly (NYSE:LLY), Amgen (NASDAQ:AMGN), Pfizer (NYSE:PFE)
On Tuesday, the European Union’s drug regulator expanded its investigation into the risk of suicidal thoughts and self-injury among patients taking weight loss and diabetes medications, including those produced by…